GlassScriptPhysician profile
Binu Shajimon
NPI 1922322197
$1,986.25
in general payments reported to CMS, 2019-2025
17 companies · $517 in 2025
The $517 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.36 · 2022: $41.42 · 2023: $616 · 2024: $719 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,852.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $658.08 | 2023-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $417.04 | 2023-2024 | Camzyos, Eliquis |
| Pfizer INC. | $245.63 | 2022-2025 | |
| Novo Nordisk INC | $142.29 | 2024-2025 | Ozempic |
| Novartis Pharmaceuticals Corporation | $101.14 | 2024-2025 | |
| Boston Scientific Corporation | $80.25 | 2024 | Eluvia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.03 | 2023-2025 | Lifevest |
| Bridgebio Pharma, INC. | $40.28 | 2025 | Attruby |
| Abbott Laboratories | $39.72 | 2021 | |
| Medtronic, INC. | $36.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $28.37 | 2024 | Wainua |
| Alnylam Pharmaceuticals INC. | $26.43 | 2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $25.51 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $25.38 | 2023 | Xarelto |
| Heartflow, INC. | $22.47 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.64 | 2021 | |
| Edwards Lifesciences Corporation | $14.99 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Binu Shajimon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.